Noom Band: A Wearable for Continuous Metabolic Health Monitoring
Noom is expanding its digital health platform with the launch of Noom Band, a wrist-worn wearable designed specifically to support weight management and metabolic health. Developed in collaboration with sensor technology company Sensor Bio, the screen-free device will be fully integrated into the existing Noom app.
How does the product work?
Noom Band continuously tracks several physiological parameters:
Heart rate and heart rate variability (HRV)
Blood oxygen saturation (SpO₂)
Sleep patterns and duration
Physical activity
The collected data is transmitted directly to the Noom app, where it is combined with existing information on nutrition, exercise and user behaviour. Noom uses these insights to provide personalized recommendations and support users in developing healthier long-term habits. Sensor Bio provides the validated sensor technology and physiological data, while Noom is responsible for interpreting the signals and integrating them into its health programmes.
What is the intended benefit?
Until now, Noom lacked continuous physiological data, particularly regarding sleep and physical activity. The wearable is intended to close this gap and provide a more comprehensive picture of an individual's health. Additional indicators such as sleep quality, daily steps and recovery can also help maintain user motivation, especially when weight loss temporarily stagnates.
According to Noom, an analysis of its Noom Med members taking GLP-1 medication found that those using a connected wearable were 34% more likely to lose at least 20 pounds within four months than those without one. However, these company-reported findings do not establish a causal effect of Noom Band itself.
Strategic significance: Noom is positioning the Band not as a standalone fitness tracker, but as part of an integrated healthcare platform combining wearable data, behavioural interventions, telehealth, diagnostics and medication-based treatment. Starting in early 2027, the device will be offered through existing employer and health plan partnerships at no additional upfront cost. The long-term objective is to demonstrate measurable improvements in weight, blood pressure and HbA1c, while strengthening the role of continuous wearable monitoring in chronic disease management.
